Compare Danaher Corporation (DHR) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Danaher Corporation trades at $197.72 (market cap $140.88B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.61. The key difference: Danaher Corporation pays a 0.8% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Danaher Corporation is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| DHR | USIG | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Fixed Income |
52-Week High | $242.05 | $52.69 |
52-Week Low | $161.91 | $50.50 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
USIG trades at $50.50, down 0.4% with bearish technical signals from moving averages but oversold RSI readings. The ETF shows consistent dividend distributions with three payments scheduled for mid-2026. Short interest surged 63.4% in April 2026, indicating increased bearish sentiment among traders despite the investment-grade corporate bond focus.
The ETF faces headwinds from rising short interest and bearish technical momentum, though oversold conditions suggest potential near-term stabilization. Investment-grade corporate bond exposure provides relative safety, but interest rate sensitivity remains a key risk factor for fixed income ETFs in the current market environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
